AGL 24.24 Increased By ▲ 0.77 (3.28%)
AIRLINK 107.70 Increased By ▲ 1.59 (1.5%)
BOP 5.12 Decreased By ▼ -0.05 (-0.97%)
CNERGY 3.63 Decreased By ▼ -0.03 (-0.82%)
DCL 7.32 Decreased By ▼ -0.48 (-6.15%)
DFML 42.10 Decreased By ▼ -2.09 (-4.73%)
DGKC 88.80 Increased By ▲ 0.30 (0.34%)
FCCL 21.75 No Change ▼ 0.00 (0%)
FFBL 41.85 Decreased By ▼ -0.67 (-1.58%)
FFL 8.61 Decreased By ▼ -0.14 (-1.6%)
HUBC 148.75 Increased By ▲ 0.95 (0.64%)
HUMNL 10.14 Decreased By ▼ -0.11 (-1.07%)
KEL 4.28 Decreased By ▼ -0.06 (-1.38%)
KOSM 3.59 Decreased By ▼ -0.20 (-5.28%)
MLCF 36.20 Decreased By ▼ -0.20 (-0.55%)
NBP 47.75 Decreased By ▼ -1.55 (-3.14%)
OGDC 129.10 Decreased By ▼ -1.75 (-1.34%)
PAEL 25.75 Decreased By ▼ -0.20 (-0.77%)
PIBTL 6.00 Decreased By ▼ -0.05 (-0.83%)
PPL 113.65 Decreased By ▼ -0.90 (-0.79%)
PRL 22.30 Decreased By ▼ -0.30 (-1.33%)
PTC 12.10 Decreased By ▼ -0.27 (-2.18%)
SEARL 54.98 Decreased By ▼ -0.72 (-1.29%)
TELE 7.11 Decreased By ▼ -0.14 (-1.93%)
TOMCL 37.11 Increased By ▲ 0.71 (1.95%)
TPLP 7.76 Decreased By ▼ -0.19 (-2.39%)
TREET 15.00 Decreased By ▼ -0.29 (-1.9%)
TRG 55.54 Decreased By ▼ -1.16 (-2.05%)
UNITY 31.20 Decreased By ▼ -0.65 (-2.04%)
WTL 1.15 Decreased By ▼ -0.02 (-1.71%)
BR100 8,248 Decreased By -46.7 (-0.56%)
BR30 25,878 Decreased By -223.8 (-0.86%)
KSE100 78,030 Decreased By -439.8 (-0.56%)
KSE30 25,084 Decreased By -114.2 (-0.45%)

Moderna

Pfizer seeks US approval to ease handling of COVID-19 vaccine

Pfizer seeks US approval to ease handling of COVID-19 vaccine

  • Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose shot, won the US emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts.
  • The data submitted may facilitate the handling of our vaccine in pharmacies and provide vaccination centers an even greater flexibility.
Published 19 Feb, 2021 07:23pm
Rich nations stockpiling a billion more COVID-19 vaccine shots than needed: Report
World

Rich nations stockpiling a billion more COVID-19 vaccine shots than needed: Report

  • In an analysis of current supply deals for COVID-19 vaccines, the ONE Campaign said wealthy countries, such as the United States and Britain, should share the excess doses to “supercharge” a fully global response to the pandemic.
  • On Thursday, the World Health Organization urged nations with vaccines not to share them unilaterally, but to donate them to the global COVAX scheme to ensure fairness.
Updated 19 Feb, 2021 02:55pm
Norway says Moderna vaccine deliveries delayed by one week
World

Norway says Moderna vaccine deliveries delayed by one week

  • There was supposed to have come 43,000 doses (next week), and those have been delayed to (the following week) according to our information.
  • As of Tuesday, close to 180,000 individuals in Norway had received their first dose of vaccine against the disease and close to 50,000 had received their second shot.
Published 10 Feb, 2021 07:58pm
J&J's COVID-19 vaccine 66pc effective in large global trial
Business & Finance

J&J's COVID-19 vaccine 66pc effective in large global trial

  • A high bar has been set by two authorized vaccines from Pfizer/BioNTech and Moderna, which were around 95% effective in preventing symptomatic illness in pivotal trials when given in two doses.
  • J&J's main goal was the prevention of moderate to severe COVID-19, and the vaccine was 85% effective in stopping severe disease.
Published 29 Jan, 2021 07:16pm
Latest on worldwide spread of the coronavirus
World

Latest on worldwide spread of the coronavirus

  • The daily number of new coronavirus infections in France stayed above 20,000 on average for the fourth straight day on Tuesday, while hospitalisations reached an eight-week high of 27,041.
Published 27 Jan, 2021 02:49pm
Moderna says COVID-19 vaccine effective against UK, South Africa variants
World

Moderna says COVID-19 vaccine effective against UK, South Africa variants

  • The company reported findings from a study that used blood samples from eight people, who had two shots of the vaccine, and two monkey and two monkeys that had also been immunised.
  • The results have not been published or peer-reviewed yet, but have been submitted to bioRxiv, which posts preliminary studies online.
Updated 25 Jan, 2021 07:06pm